• Skip to main content
ISC
ISC
  • Program
  • #ISC26
Topics
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Photo Gallery
Resources
  • Program
  • #ISC26
User Tools
  • Privacy Policy
  • Terms & Conditions
  • Accessibility Statement
Twitter X icon YouTube iconPinterest iconLinkedIn icon
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Photo Gallery
Topics
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Photo Gallery
Resources
  • Program
  • #ISC26
User Tools
  • Privacy Policy
  • Terms & Conditions
  • Accessibility Statement
Twitter X icon YouTube iconPinterest iconLinkedIn icon
Feb 9th, 2022

Refining clinical assessment with NIH Stroke Scale

Learn to better gauge the reliability and validity of stroke severity assessment findings using the NIH Stroke Scale.


headshot of Randi Toumbs
Randi Toumbs, RN

Although it was originally designed as a research tool for measuring data on patients in stroke clinical trials, the National Institutes of Health (NIH) Stroke Scale has come to be relied upon more and more by stroke professionals as a clinical assessment tool for evaluating the acuity of stroke patients, determining the appropriate treatment and predicting the outcomes for those patients.

It is worth noting the scale is not without its limitations, some of which will be highlighted in the session “Leveraging the National Institute of Health (NIH) Stroke Scale Knowledge and Skills.”

Randi Toumbs, RN, clinical specialist for the stroke and neurology service at Memorial Hermann Hospital in Houston, will lead a discussion focusing on a number of tricky areas for consideration, including which patients are appropriate and when to use the assessment tool, how to perform a comprehensive assessment of the eyes, and understanding the physiologic alterations associated with visual neglect and extinction.

“These areas are very detailed and common causes of questions among clinicians in performing the assessment,” Toumbs said. 

As mentioned, there is wider use of the NIH Stroke Scale. Additionally, there are regulatory requirements for the use of the NIH Stroke Scale in primary stroke centers of care to maintain their credentialing status.   

The convergence of the assessment complexity in scoring a patient’s stroke severity using the NIH Stroke Scale in conjunction with the impetus of increasing the number of institutions seeking regulatory compliance provides an important educational opportunity. The Stroke Nursing Program Committee developed this session for the International Stroke Conference in order to provide a learning forum for stroke providers with the goal of improving competencies in measuring stroke severity through the application of the NIH Stroke Scale.

Toumbs said she is hopeful attendees of the session will come away with not just a better understanding of the history of the stroke scale but how to better gauge the reliability and validity of stroke severity assessment findings using the NIH Stroke Scale as well as other tools to consider to quantify stroke patient disposition.

Skye Coote, BN, senior project manager for clinical education at the Australian Stroke Alliance in Melbourne, will give an overview of how to measure stroke severity using the NIH Stroke Scale.  Her presentation will also include why the scale is used, when and discerning which patients are most appropriate for the application of the scale in the clinical setting. Following the session, attendees will be able to describe the history and psychometric properties of the scale, identify patient diagnoses suitable for using the scale and discuss the limitations of scoring using the scale.

Alicia Richardson, MSN, clinical nurse specialist at Penn State Health’s Milton S. Hershey Medical Center in Hershey, Pennsylvania, will explore gaze and visual field disorders. Following her presentation, attendees will be able to distinguish gaze disorder findings in anterior versus posterior circulation, describe visual field disorder findings associated with anterior and posterior circulation stroke, and correctly score the NIH Stroke Scale to reflect deficits in gaze and visual field disorders.

In addition, Dawn Meyer, PhD, associate professor of neurosciences at the University of California-San Diego School of Medicine, will talk about the importance of not neglecting extinction disorders. Attendees will be able to describe the physiologic alterations associated with neglect syndromes, distinguish visual neglect and gaze preferences from visual field and gaze disorders and correctly score the NIH Stroke Scale to reflect deficits in extinction disorders by the end of the session.

“We hope attendees will have better insight into the NIH Stroke Scale and learn how to avoid common pitfalls in some of the trickier assessment components,” Toumbs said. 

See the Online Program Planner for specific programming information. 

For more ISC 2022 coverage, visit International Stroke Conference Coverage. 

Interesting Stories
Cholesterol for Professionals
Sponsored by American Heart Association/American Stroke Association
Cholesterol for Professionals
Stroke Risks and Prevention
Sponsored by American Heart Association/American Stroke Association
Stroke Risks and Prevention
WATCH | Stroke prevention in patients with atrial fibrillation: Left atrial appendage closure to protect the brain
Sponsored by Boston Scientific
WATCH | Stroke prevention in patients with atrial fibrillation: Left atrial appendage closure to protect the brain
Let's lead the charge in stroke care. Together.
Sponsored by Joint Commission
Let's lead the charge in stroke care. Together.
More Content
Lb 03 Audience
Daily Coverage
#ISC26 Closing Main Event reports on SPAN2, I-ACQUIRE, LAIS, LUMOSA, CONCERN, MeVO, DISTALS and BCI-REHAB trials
Feb 9th, 2026
Lbs02 Audience
Daily Coverage
Late-Breaking Science reveals findings on adjunct intra-arterial thrombolysis, TNK, tirofiban and more
Feb 9th, 2026
Posters 0108
Home
Catch up on all the #ISC26 posters you missed at the conference
Feb 8th, 2026
From left to right: Ángel Chamorro, Joseph Broderick and Ronald M. Lazar.
Daily Coverage
CHOICE-2, FASTEST and CREST 2 results revealed during Opening Main Event
Feb 5th, 2026
Samarth Shah, PharmD, BCPS, and Alireza Atri, MD, PhD
Daily Coverage
GLP-1s: From weight loss to brain gain
Feb 5th, 2026
Kori S. Zachrison, MD, MSc, FAHA, Nestor R. Gonzalez, MD, FAHA, and Shyam Prabhakaran, MD, MS, FAHA
Daily Coverage
Assessing changes, additions to 2026 acute ischemic stroke guideline
Feb 5th, 2026
James Meschia, MD, FAHA, and John Huston, MD
Daily Coverage
Intensive medical management, revascularization and algorithms
Feb 5th, 2026
Guillaume Paré, MD
Daily Coverage
Polygenic risk scores: Potential game changer
Feb 5th, 2026
Nancy Brown
Daily Coverage
CEO highlights Heart Association accomplishments
Feb 5th, 2026
Stacey E. Rosen, MD
Daily Coverage
Sex matters: Closing the gender gap in research and medicine
Feb 5th, 2026
Mary Cushman, MD, MSc, FAHA, and Babak Navi, MD, MS
Daily Coverage
Cancer and ischemic stroke
Feb 4th, 2026
Rami Morsi, MD, and Kazutaka Uchida, MD, PhD
Daily Coverage
New research emerges on LVOs
Feb 4th, 2026